Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies

Triple negative breast cancer (TNBC) is classically treated with combination chemotherapies. Although, initially responsive to chemotherapies, TNBC patients frequently develop drug-resistant, metastatic disease. Chemotherapy resistance can develop through many mechanisms, including induction of a tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakrabarty, Anindita, Chakraborty, Shayantani, Bhattacharya, Ranjini, Chowdhury, Goutam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264500/
https://www.ncbi.nlm.nih.gov/pubmed/34249714
http://dx.doi.org/10.3389/fonc.2021.674354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264500/
https://www.ncbi.nlm.nih.gov/pubmed/34249714
http://dx.doi.org/10.3389/fonc.2021.674354

Ejemplares similares